Skrivanek, Zachary
Eli Lilly (United States)
2 papers on CoChat
Most cited papers
- Verified
Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)
Nauck, M., Weinstock, R. S., Umpierrez, G. E., Guerci, B., Skrivanek, Z., & Milicevic, Z. (2014) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 284
- Verified
Exenatide effects on statin pharmacokinetics and lipid response
Kothare, P. A., Linnebjerg, H., Skrivanek, Z., Reddy, S., Mace, K., Pena, A., Han, J., Fineman, M., & Mitchell, M. (2007) · Int. Journal of Clinical Pharmacology and Therapeutics
Lipoproteins and Cardiovascular HealthPharmacogenetics and Drug Metabolism
Cited by 36
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free